Related Experiment Video
Updated: Feb 8, 2026

miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
SB225002 inhibits prostate cancer invasion and attenuates the expression of BSP, OPN and MMP‑2
Meng Xu1, Huamao Jiang2, Haiguang Wang1
1Department of Urology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning 121000, P.R. China.
Abstract:
The mechanisms of malignant cell metastasis to secondary sites are complex and multifactorial. Studies have demonstrated that small integrin‑binding ligand N‑linked glycoproteins (SIBLINGs), particularly bone sialoprotein (BSP) and osteopontin (OPN), are involved in neoplastic growth and metastasis. SIBLINGs promote malignant cell invasion and metastasis by enhancing matrix metalloproteinase 2 (MMP‑2) and MMP‑9 expression. Moreover, BSP and OPN can combine with integrin, which is located on the tumor cell surface, to further promote the malignant behavior of tumor cells. In the present study, we investigated whether SB225002, a specific CXCR2 receptor antagonist, can inhibit prostate cancer cell expression of BSP and OPN and reduce cancer cell invasion ability. A series of experiments showed that after SB225002 treatment, the proliferation, invasion and migration of two androgen‑independent prostate cancer cell lines were inhibited, but this inhibitory effect was not observed on androgen‑dependent prostate cancer cells. Western blotting showed that the PI3K signaling pathway could regulate the expression of SIBLING and MMP family proteins, and SB22055 could reduce the expression of BSP, OPN and MMP‑2 in prostate cancer cells by inhibiting AKT/mTOR phosphorylation. Finally, in vivo experiments confirmed that SB225002 inhibited the proliferation of prostate cancer cells in vivo, and the expression levels of BSP, OPN and MMP‑2 were also inhibited.
Insights
SB225002, a CXCR2 antagonist, inhibits prostate cancer cell invasion by reducing SIBLINGs (small integrin-binding ligand N-linked glycoproteins) like BSP and OPN, and MMP-2 expression, particularly in androgen-independent cells.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Malignant cell metastasis is complex, involving small integrin-binding ligand N-linked glycoproteins (SIBLINGs) like bone sialoprotein (BSP) and osteopontin (OPN).
- SIBLINGs enhance matrix metalloproteinase (MMP)-2 and MMP-9 expression, promoting cancer cell invasion and metastasis.
- BSP and OPN interact with tumor cell surface integrins, further driving malignant behavior.
Purpose of the Study:
- To investigate if SB225002, a CXCR2 receptor antagonist, can inhibit prostate cancer cell expression of BSP and OPN.
- To determine if SB225002 can reduce prostate cancer cell invasion ability.
- To explore the role of the PI3K signaling pathway in mediating these effects.
Main Methods:
- Treatment of androgen-independent and androgen-dependent prostate cancer cell lines with SB225002.
- Western blotting to analyze protein expression, including SIBLINGs, MMPs, and components of the PI3K/AKT/mTOR pathway.
- In vivo experiments using mouse models to assess tumor growth and metastasis.
Main Results:
- SB225002 inhibited proliferation, invasion, and migration of androgen-independent prostate cancer cells, but not androgen-dependent cells.
- SB225002 reduced the expression of BSP, OPN, and MMP-2 in prostate cancer cells.
- Inhibition of AKT/mTOR phosphorylation by SB225002 was linked to reduced SIBLING and MMP expression.
- In vivo studies confirmed SB225002 inhibited prostate cancer cell proliferation and reduced BSP, OPN, and MMP-2 levels.
Conclusions:
- SB225002 effectively inhibits the proliferation and invasion of androgen-independent prostate cancer cells.
- The anti-metastatic effects of SB225002 are mediated through the inhibition of SIBLINGs (BSP, OPN) and MMP-2 expression via the PI3K/AKT/mTOR pathway.
- CXCR2 receptor antagonism presents a potential therapeutic strategy for advanced prostate cancer.
Related Concept Videos
Transcription Attenuation in Prokaryotes
There are several different mechanisms used to attenuate transcription. In ribosome mediated...
Feedback Inhibition
What is Gene Expression?
Gene expression is the process in which DNA directs the synthesis of functional products, that is, proteins. Cells can regulate gene expression at various stages. It allows organisms to generate different cell types and enables cells to adapt to internal and external factors.
Genetic Information Flows from DNA to RNA to Protein
A gene is a stretch of DNA that serves as the blueprint for functional RNAs and proteins. Since DNA is made up of nucleotides and proteins consist of amino...
Enzyme Inhibition
Inhibition of Cdk Activity
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

